OraSure Technologies, Inc. (OSUR) is a Medical - Instruments & Supplies company in the Healthcare sector, currently trading at $3.21. It has a SharesGrow Score of 51/100, indicating a mixed investment profile with 2 out of 7 criteria passed.
Analyst consensus target is OSUR = $4 (+24.6% upside).
Valuation: OSUR trades at a trailing Price-to-Earnings (P/E) of -3.2 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 0.3.
Financials: revenue is $115M, -29.2%/yr average growth. Net income is $69M (loss), growing at +3.5%/yr. Net profit margin is -59.8% (negative). Gross margin is 41.9% (+3.8 pp trend).
Balance sheet: total debt is $13M against $341M equity (Debt-to-Equity (D/E) ratio 0.04, conservative). Current ratio is 6.58 (strong liquidity). Debt-to-assets is 3.3%. Total assets: $403M.
Analyst outlook: 4 / 13 analysts rate OSUR as buy (31%) — mixed sentiment.
SharesGrow 7-Criteria breakdown: Value 92/100 (Pass), Growth 30/100 (Fail), Past 25/100 (Fail), Health 100/100 (Pass), Moat 51/100 (Partial), Future 46/100 (Partial), Income 10/100 (Fail).
